TheTechno Optimist.

CMR Surgical—Versius surpasses 45,000 completed surgical procedures globallyCMR Surgical—Versius gains CE Mark approval for paediatric surgeryCMR Surgical—Versius Plus receives FDA 510(k) clearance for cholecystectomy

CMR Surgical

Surgical robot, Versius, minimal access surgery

GB$3B private~681 staffest. 2014cmrsurgical.com (opens cmrsurgical.com)Checked 10 Oct

The brief

Analyst view
  • Achieved unicorn status in 2019 at $1B+ valuation; Series D in 2021 at $3 billion.
  • Versius operates at 20+ NHS hospital partnerships in the UK and internationally across multiple surgical specialties.
  • Secured $200M in April 2025. FDA De Novo October 2024. FDA 510(k) cleared December 2025. CE Mark paediatric January 2026.

Technical approach

As reported
Modularity

Arms attach to standard fixtures

Versius arms connect to standard OR tables and frames, so hospitals need no custom infrastructure changes.

Familiar interface

Laparoscopic port placement

The system uses traditional laparoscopic port positions, so surgeons leverage their existing training and don't need to learn new access techniques.

Digital ecosystem

Data analytics for outcomes

CMR provides digital tools to help hospitals analyze patient outcomes and operational efficiency, supporting evidence-based adoption.

Primer